Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Y A Doritchamou

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMC Medicine|September 10, 2021
Can complement fix placental malaria?Justin Y A Doritchamou, Patrick E Duffy
Frontiers in Immunology|January 3, 2022
Editorial: Immunity to Parasitic Infections in PregnancyJustin Y A Doritchamou, Elizabeth H Aitken, Adrian J F Luty
Plos Pathogens|May 25, 2023
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?Justin Y A Doritchamou, Jonathan P Renn, Lars Hviid, et al.
Plos Pathogens|January 29, 2024
Correction: A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?Justin Y A Doritchamou, Jonathan P Renn, Lars Hviid, et al.
Elife|February 1, 2022
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolatesJustin Y A Doritchamou, Jonathan P Renn, Bethany Jenkins, et al.
Communications Biology|December 17, 2019
Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some <i>Plasmodium falciparum</i> strainsJustin Y A Doritchamou, Robert Morrison, Jonathan P Renn, et al.
Plos Neglected Tropical Diseases|February 13, 2018
Submicroscopic placental infection by non-falciparum Plasmodium sppJustin Y A Doritchamou, Richard A Akuffo, Azizath Moussiliou, et al.
Communications Biology|November 20, 2021
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Communications Biology|April 27, 2022
Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Plos Pathogens|March 4, 2024
Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccineRui Ma, Nichole D Salinas, Sachy Orr-Gonzalez, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMC Medicine|September 10, 2021
Can complement fix placental malaria?Justin Y A Doritchamou, Patrick E Duffy
Frontiers in Immunology|January 3, 2022
Editorial: Immunity to Parasitic Infections in PregnancyJustin Y A Doritchamou, Elizabeth H Aitken, Adrian J F Luty
Plos Pathogens|May 25, 2023
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?Justin Y A Doritchamou, Jonathan P Renn, Lars Hviid, et al.
Plos Pathogens|January 29, 2024
Correction: A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?Justin Y A Doritchamou, Jonathan P Renn, Lars Hviid, et al.
Elife|February 1, 2022
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolatesJustin Y A Doritchamou, Jonathan P Renn, Bethany Jenkins, et al.
Communications Biology|December 17, 2019
Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some <i>Plasmodium falciparum</i> strainsJustin Y A Doritchamou, Robert Morrison, Jonathan P Renn, et al.
Plos Neglected Tropical Diseases|February 13, 2018
Submicroscopic placental infection by non-falciparum Plasmodium sppJustin Y A Doritchamou, Richard A Akuffo, Azizath Moussiliou, et al.
Communications Biology|November 20, 2021
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Communications Biology|April 27, 2022
Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Plos Pathogens|March 4, 2024
Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccineRui Ma, Nichole D Salinas, Sachy Orr-Gonzalez, et al.
Pageof 2